We are pleased to share that the SEC of the MOH of Ukraine has developed new Guidelines for Clinical Trials of Medicinal Products for the Treatment and Prevention of Diabetes.
This important step provides researchers and sponsors with clearer regulatory guidance to ensure high-quality and patient-focused diabetes studies in Ukraine. It also highlights the country’s ongoing commitment to advancing clinical research and improving access to innovative therapies.
At Pharmaxi LLC, we welcome this development and remain committed to supporting our clients in navigating the evolving regulatory landscape.
If you’re planning or considering clinical trials for patients with diabetes, Pharmaxi LLC would be glad to support you as a hashtagfullserviceCRO. With our strong local expertise and international experience, we are ready to ensure efficient study start-up and successful project delivery.
